Background: Symptoms are among the most important factors impacting quality of life (QOL) in hypertrophic cardiomyopathy (HCM) patients, and reflect a poor prognosis. Whether emotional stress can ...

Take hypertrophic cardiomyopathy, or HCM, a primarily genetic condition that results in a thickening of the walls of the heart—specifically its left ventricle, which is the chamber that pumps ...

Diagnosis: Takotsubo cardiomyopathy Management: Treatment with β-blockers, aspirin, angiotensin-converting-enzyme inhibitors, and intravenous diuretics. A 71-year-old woman presented to an ...

People with hypertrophic cardiomyopathy (HCM) have a greater risk of becoming severely ill from COVID-19. Furthermore, the virus has been found to significantly damage the heart muscle, causing ...

Arrhythmogenic right ventricular cardiomyopathy (ARVC), also known as arrhythmogenic cardiomyopathy, is a genetic condition affecting your heart muscle. It affects about 1 in 2,000 to 1 in 5,000 ...

The 2024 guideline for cardiovascular management of adults undergoing noncardiac surgery reflects a decade of updates and new ...

Since the first global consensus document eight years ago, research in the field of atrial cardiomyopathy has made considerable progress. Prof. Goette summarizes the key findings of the current ...

is associated with increased morbidity and mortality in patients with hypertrophic cardiomyopathy (HCM). The primary aim of this study (HCM Risk-AF) was to determine the predictors of AF in a large ...

The aim of this study was to explore the clinical implications of a HTS strategy for patients with hypertrophic cardiomyopathy (HCM) using a targeted HTS methodology and workflow developed for ...